Lncrna sema3b-as1 inhibits breast cancer progression by targeting mir-3940/klln axis

HIGHLIGHTS

  • who: Jin Hu from the (UNIVERSITY) have published the paper: LncRNA SEMA3B-AS1 inhibits breast cancer progression by targeting miR-3940/KLLN axis, in the Journal: (JOURNAL) of 12/03/2022
  • what: The authors investigated the role of lncRNA SEMA3B-AS1 (SEAS1) in breast cancer progression and the underlying mechanisms. The vitro rescue experiment was conducted to evaluate the regulatory role that KLLN plays in miR-3940-3p mediated TNBC progression. The authors demonstrated that miR-3940-3p was regulated by SEAS1. This study demonstrated that KLLN was a tumor suppressor in TNBC cells.
  •  

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?